Patents by Inventor Jens Dhein

Jens Dhein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Detection of Ischemic Strokes
    Publication number: 20170242039
    Abstract: The present invention relates to the identification and use of diagnostic markers for ischemic stroke of the lacunar subtype. The invention relates to devices and kits for performing these methods.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 24, 2017
    Applicants: Abbott GmbH & Co. KG, Fundacio Hospital Universitari Vall D'Hebron - Institut de Recerca (HUVH IR)
    Inventors: Ingo Curdt, Stuart Blincko, Jens Dhein, Viswanath Devanarayan, Joan Montaner Villalonga
  • Method for Detection of Ischemic Strokes
    Publication number: 20130122519
    Abstract: The present invention relates to the identification and use of diagnostic markers for ischemic stroke of the lacunar subtype. The invention relates to devices and kits for performing these methods.
    Type: Application
    Filed: July 28, 2011
    Publication date: May 16, 2013
    Applicants: Institut de recerca Hoepital Universitari Vall D'Heerbron, Fundacio Privada, ABBOTT GMBH & CO. KG
    Inventors: Ingo Curdt, Stuart Blincko, Jens Dhein, Viswanath Devanarayan, Joan Montaner Villalonga
  • Apoptosis inhibitors
    Publication number: 20070207160
    Abstract: This invention relates to compositions for inhibiting apoptosis, containing one to all components of: (a) an APO-1-inhibiting compound; (b) a compound inhibiting and catching, respectively, the APO-1 ligand; and (c) a compound inhibiting the intracellular APO-1 signalling pathway, the component(s) being not considered foreign in an individual, as well as conventional excipients. Furthermore, this invention relates to compounds suitable for inhibiting apoptosis and having at least one extracellular APO-1 domain and a carrier, the domain(s) and the carrier being not considered foreign in an individual.
    Type: Application
    Filed: February 14, 2007
    Publication date: September 6, 2007
    Inventors: Peter Krammer, Michael Westendorp, Klaus Schulze-Osthoff, Klaus-Michael Debatin, Rainer Frank, Jens Dhein, Henning Walczak, Eckart Knipping, Kirstin Stricker
  • Monoclonal antibodies to the APO-1 antigen
    Patent number: 5891434
    Abstract: The APO-1 cellular membrane antigen, an about 50 kDa antigen associated with cellular apoptosis, and purified cDNA encoding same is described. The antigen is expressed by numerous normal and malignant cells, including activated and malignant lymphoid cells. Also disclosed are antibodies which bind the antigen, and which induce growth inhibition and apoptosis.
    Type: Grant
    Filed: March 23, 1995
    Date of Patent: April 6, 1999
    Assignee: Centocor, Inc.
    Inventors: Peter H. Krammer, Klaus-Michael Debatin, Bernhard C. Trauth, Iris Behrmann, Jens Dhein, Christiane Klas, Peter Moller, Werner Falk, Alexander Oehm, Peter T. Daniel